HomeInvestors HealthPaulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves By BOMAR ENT. November 15, 2024 FacebookTwitterPinterestWhatsApp bodnarchuk/iStock via Getty Images Paulson & Co. exited its position in AngloGold Ashanti (NYSE:AU) in Q3, according to the fund’s latest 13F filing. The fund increased its stake in Madrigal Pharmaceuticals. Paulson & Co. also reduced its position in Altice USA (ATUS) in Source link Previous articlePassive Income Strategy for Stocks and Options | Covered Calls Tutorial #stocksNext articleStock market news today: Tech gains, Dow lags on heels of slowing labor market demand | 12/5/23 latest articles explore more How Much SHOULD You Put Down on an Investment Property? Amsterdam Financial History Tour by Old Amsterdam Tours Don’t Bother With Costco’s Executive Membership Unless You Do This 2024 Election: Voter Turnout & Market Impact! Macroeconomics For Investors | ft. @The Plain Bagel How to Trade Options: The Complete Guide for Beginners (Options Trading for Beginners Crash Course Book 2024) LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.